컨슈머 헬스 위탁생산 시장 보고서(2026년)
Consumer Health Contract Manufacturing Global Market Report 2026
상품코드 : 1951651
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,754,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,763,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,772,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

컨슈머 헬스 위탁생산 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 1,556억 2,000만 달러에서 2026년에는 1,741억 9,000만 달러로, CAGR 11.9%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장 요인으로는 자체 제조 능력의 한계, 소비자 헬스케어 제품에 대한 수요 증가, 비용 최적화에 대한 관심 증가, 중소 브랜드 증가, 전문 제조 노하우 부족 등을 꼽을 수 있습니다.

컨슈머 헬스 위탁생산 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 2,703억 달러에 달하고, CAGR은 11.6%를 기록할 전망입니다. 예측 기간 동안 성장 요인으로는 위탁 제조 시설의 확대, 첨단 자동화 및 인더스트리 4.0 기술 도입, 소비자 건강 인식 증가, 퍼스널케어 제품의 세계 아웃소싱 증가, 디지털 공급망 관리 시스템 통합 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 외주 OTC 의약품 제조에 대한 수요 증가, 영양 보충제 및 퍼스널케어 위탁 서비스 성장, 규제 준수 및 품질 표준에 대한 관심 증가, 포장 및 라벨링 솔루션 확대, 유연한 제조 파트너십 도입 증가 등을 꼽을 수 있습니다.

소비자 건강 제품에 대한 수요 증가는 향후 몇 년 동안 소비자 건강 위탁생산 시장의 성장을 견인할 것으로 예상됩니다. 소비자 건강 제품에는 처방전 없이 개인 건강관리에 사용되는 일반의약품, 건강보조식품, 퍼스널케어 제품 등이 포함됩니다. 더 많은 소비자들이 셀프케어를 우선시하고 의료진을 자주 방문하지 않고도 건강을 유지할 수 있는 편리한 일반의약품을 선호함에 따라, 이러한 제품에 대한 수요가 증가하고 있습니다. 컨슈머 헬스 위탁생산은 기업이 전문 제조업체에 아웃소싱을 통해 고품질 제품을 효율적으로 생산할 수 있도록함으로써 이러한 추세를 지원하고, 브랜드 소유자는 제품 혁신, 마케팅, 유통에 집중할 수 있도록 합니다. 예를 들어,2024년9월,영국 소매은행 바클레이즈 은행(Barclays Bank UK PLC)에 따르면,2024년7월과 8월 데이터에 따르면,2024년8월 소비자 지출은 전년 대비 7.3% 증가하여 건강 및 미용 부문의 실적이 호조를 보였고,2024년8월 소비자 지출은 전년 대비 7.3% 증가했습니다. 따라서 소비자 건강 제품에 대한 수요 증가는 컨슈머 헬스 위탁생산 시장의 성장에 기여하고 있습니다.

컨슈머 헬스 위탁생산 시장에서 사업을 전개하는 주요 기업들은 생산 워크플로우 최적화, 확장성 향상, 소비자 건강 제품 시장 출시 시간 단축을 위해 위탁 개발 및 제조 플랫폼과 같은 혁신적인 솔루션 도입에 중점을 두고 있습니다. 위탁개발 제조 플랫폼은 제품 개발 활동(제형 개발 및 시험 포함)과 대규모 제조 역량을 단일 프레임워크 내에서 통합한 서비스 모델입니다. 예를 들어, 2023년 10월 캐나다의 미생물 개발 전문 기업 랄만(Lalman)은 차세대 프로바이오틱스 및 바이오 치료 제품의 개발 및 생산을 지원하는 종합 위탁 개발 제조 플랫폼 'Expert Biome CDMO'를 출범했습니다. 이 플랫폼은 미생물 균주 연구개발, 바이오프로세스 스케일업, 의약품 제조, 제형화, 규제 대응 지원까지 포괄하는 엔드투엔드 서비스를 제공합니다. cGMP Pharma 등 엄격한 품질 기준 하에 운영되는 Expert Biome은 건강보조식품 및 바이오 치료제 시장의 주요 과제를 해결하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM
영문 목차

영문목차

Consumer health contract manufacturing involves outsourcing the production of consumer health products, such as over-the-counter (OTC) medicines, dietary supplements, and personal care items, to specialized third-party manufacturers. This strategy allows brand owners to focus on key activities like marketing, distribution, and product development while leveraging the manufacturing expertise, regulatory compliance capabilities, and cost advantages of contract manufacturing partners.

The main product types in consumer health contract manufacturing include over-the-counter (OTC) drugs, nutritional supplements, personal care products, medical devices, and others. Over-the-counter (OTC) drugs are medications available without a prescription and are commonly used to treat everyday health issues such as pain, allergies, and cold symptoms. The services provided include active pharmaceutical ingredient (API) manufacturing, finished dosage manufacturing, medical device manufacturing, packaging and labeling, and other related services. These offerings serve a wide range of end users, including pharmaceutical and biopharmaceutical companies, nutraceutical companies, cosmeceutical companies, medical device companies, and others.

Tariffs have influenced the consumer health contract manufacturing market by increasing the cost of imported raw materials, active pharmaceutical ingredients (APIs), and packaging components. Segments like OTC drugs, nutritional supplements, and medical devices are particularly affected, with Asia-Pacific regions such as China and India experiencing higher import duties. This has resulted in elevated production costs and delayed timelines. On the positive side, tariffs have encouraged local sourcing, investment in domestic manufacturing capabilities, and innovation in cost-efficient production methods.

The consumer health contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides consumer health contract manufacturing market statistics, including consumer health contract manufacturing industry global market size, regional shares, competitors with a consumer health contract manufacturing market share, detailed consumer health contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the consumer health contract manufacturing industry. This consumer health contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The consumer health contract manufacturing market size has grown rapidly in recent years. It will grow from $155.62 billion in 2025 to $174.19 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to limited in-house manufacturing capabilities, rising demand for consumer health products, increasing focus on cost optimization, growing number of small and mid-size brands, lack of specialized manufacturing expertise.

The consumer health contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $270.3 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to expansion of contract manufacturing facilities, adoption of advanced automation and industry 4.0 technologies, rising consumer health awareness, increasing global outsourcing of personal care production, integration of digital supply chain management systems. Major trends in the forecast period include rising demand for outsourced otc drug manufacturing, growth in nutritional supplements and personal care contract services, increased focus on regulatory compliance and quality standards, expansion of packaging and labelling solutions, rising adoption of flexible manufacturing partnerships.

The increasing demand for consumer health products is anticipated to drive the growth of the consumer health contract manufacturing market in the coming years. Consumer health products include over-the-counter medications, dietary supplements, and personal care items that individuals use to manage their health and well-being without requiring a prescription. Demand for these products is rising as more consumers prioritize self-care and prefer convenient over-the-counter options to maintain health without frequent visits to healthcare providers. Consumer health contract manufacturing supports this trend by enabling companies to efficiently produce high-quality products through outsourcing to specialized manufacturers, allowing brand owners to concentrate on product innovation, marketing, and distribution. For instance, in September 2024, according to Barclays Bank UK PLC, a UK-based retail banking provider, data from July and August 2024 indicated strong performance in the health and beauty sector, with consumer spending increasing by 7.3% year-on-year in August 2024. Therefore, the rising demand for consumer health products is contributing to the growth of the consumer health contract manufacturing market.

Major companies operating in the consumer health contract manufacturing market are emphasizing the introduction of innovative solutions, such as contract development and manufacturing platforms, to optimize production workflows, improve scalability, and shorten time-to-market for consumer health products. A contract development and manufacturing platform is an integrated service model that combines product development activities, including formulation and testing, with large-scale manufacturing capabilities within a single framework. For instance, in October 2023, Lallemand Inc., a Canada-based company specializing in microorganism development, launched Expert Biome CDMO, a comprehensive contract development and manufacturing platform designed to support the development and production of next-generation probiotic and live biotherapeutic products. The platform delivers end-to-end services encompassing microbial strain research and development, bioprocess scale-up, drug manufacturing, formulation, and regulatory support. Operating under stringent quality standards such as cGMP Pharma, Expert Biome aims to address key challenges in the health supplements and live biotherapeutics markets.

In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. Through this acquisition, Novo Holdings seeks to reinforce Catalent's role as a leading global service provider to the pharmaceutical and biotechnology industries, supporting continued growth, innovation, and enhanced services for customers and patients worldwide, while advancing Novo Holdings' mission to invest for the benefit of people and the planet. Catalent Inc. is a US-based contract development and manufacturing organization (CDMO) that produces drug substances and finished dosage forms.

Major companies operating in the consumer health contract manufacturing market are Sirio Pharma Co. Ltd., Aenova Group, Vit-Best Nutrition Inc., Robinson Pharma Inc., Trividia Health Inc., Tishcon Corporation, SCN BestCo, Akums Drugs And Pharmaceuticals, Bactolac Pharmaceutical Inc., ION Labs Inc., Captek Softgel International.

North America was the largest region in the consumer health contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the consumer health contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the consumer health contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The consumer health contract manufacturing market consists of sales of products including herbal and botanical products, functional foods and beverages, probiotic formulations, topical health treatments, and vitamin-infused gummies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Consumer Health Contract Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses consumer health contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for consumer health contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The consumer health contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Consumer Health Contract Manufacturing Market Characteristics

3. Consumer Health Contract Manufacturing Market Supply Chain Analysis

4. Global Consumer Health Contract Manufacturing Market Trends And Strategies

5. Consumer Health Contract Manufacturing Market Analysis Of End Use Industries

6. Consumer Health Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Consumer Health Contract Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Consumer Health Contract Manufacturing Total Addressable Market (TAM) Analysis for the Market

9. Consumer Health Contract Manufacturing Market Segmentation

10. Consumer Health Contract Manufacturing Market Regional And Country Analysis

11. Asia-Pacific Consumer Health Contract Manufacturing Market

12. China Consumer Health Contract Manufacturing Market

13. India Consumer Health Contract Manufacturing Market

14. Japan Consumer Health Contract Manufacturing Market

15. Australia Consumer Health Contract Manufacturing Market

16. Indonesia Consumer Health Contract Manufacturing Market

17. South Korea Consumer Health Contract Manufacturing Market

18. Taiwan Consumer Health Contract Manufacturing Market

19. South East Asia Consumer Health Contract Manufacturing Market

20. Western Europe Consumer Health Contract Manufacturing Market

21. UK Consumer Health Contract Manufacturing Market

22. Germany Consumer Health Contract Manufacturing Market

23. France Consumer Health Contract Manufacturing Market

24. Italy Consumer Health Contract Manufacturing Market

25. Spain Consumer Health Contract Manufacturing Market

26. Eastern Europe Consumer Health Contract Manufacturing Market

27. Russia Consumer Health Contract Manufacturing Market

28. North America Consumer Health Contract Manufacturing Market

29. USA Consumer Health Contract Manufacturing Market

30. Canada Consumer Health Contract Manufacturing Market

31. South America Consumer Health Contract Manufacturing Market

32. Brazil Consumer Health Contract Manufacturing Market

33. Middle East Consumer Health Contract Manufacturing Market

34. Africa Consumer Health Contract Manufacturing Market

35. Consumer Health Contract Manufacturing Market Regulatory and Investment Landscape

36. Consumer Health Contract Manufacturing Market Competitive Landscape And Company Profiles

37. Consumer Health Contract Manufacturing Market Other Major And Innovative Companies

38. Global Consumer Health Contract Manufacturing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Consumer Health Contract Manufacturing Market

40. Consumer Health Contract Manufacturing Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기